Role of fibroblast growth factor 2 and wnt signaling in anabolic effects of parathyroid hormone on bone formation
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of fibroblast growth factor 2 and wnt signaling in anabolic effects of parathyroid hormone on bone formation
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 227, Issue 11, Pages 3539-3545
Publisher
Wiley
Online
2012-02-29
DOI
10.1002/jcp.24075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expression
- (2011) Yurong Fei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- An Irradiation-Altered Bone Marrow Microenvironment Impacts Anabolic Actions of PTH
- (2011) A. J. Koh et al. ENDOCRINOLOGY
- Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats
- (2011) Xiaodong Li et al. ENDOCRINOLOGY
- Fibroblast Growth Factor 2 Stimulation of Osteoblast Differentiation and Bone Formation Is Mediated by Modulation of the Wnt Signaling Pathway
- (2011) Yurong Fei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury
- (2011) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Parathyroid hormone regulates osteoblast differentiation in a Wnt/β-catenin-dependent manner
- (2011) Ye Tian et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression
- (2010) G. R. Heiland et al. ANNALS OF THE RHEUMATIC DISEASES
- New Approaches to the Treatment of Osteoporosis
- (2010) Barbara C. Silva et al. Annual Review of Medicine
- Transgenic mice overexpressing secreted frizzled-related proteins (sFRP)4 under the control of serum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis
- (2010) Hwa Young Cho et al. BONE
- Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells
- (2010) Liping Xiao et al. BONE
- Suppression of Wnt Signaling by Dkk1 Attenuates PTH-Mediated Stromal Cell Response and New Bone Formation
- (2010) Jun Guo et al. Cell Metabolism
- Parathyroid Hormone Receptor Directly Interacts with Dishevelled to Regulate β-Catenin Signaling and Osteoclastogenesis
- (2010) Guillermo Romero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeted overexpression of Dkk1 in osteoblasts reduces bone mass but does not impair the anabolic response to intermittent PTH treatment in mice
- (2010) Gang-Qing Yao et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Sclerostin antibody treatment enhances metaphyseal bone healing in rats
- (2010) Fredrik Agholme et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Polymorphisms in predicted miRNA binding sites and osteoporosis
- (2010) Shu-Feng Lei et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial
- (2010) Hiroshi Kawaguchi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Parathyroid Hormone Treatment on Circulating Sclerostin Levels in Postmenopausal Women
- (2010) Matthew T. Drake et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal Women
- (2010) Faryal S. Mirza et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF-2 Stimulates Periodontal Regeneration
- (2010) M. Kitamura et al. JOURNAL OF DENTAL RESEARCH
- Fibroblast Growth Factor-2 Stimulates the Proliferation of Mesenchyme-Derived Progenitor Cells From Aging Mouse and Human Bone
- (2010) G. Ou et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Fibroblast growth factor 2 positively regulates expression of activating transcription factor 4 in osteoblasts
- (2009) Yurong Fei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation
- (2009) Peter V.N. Bodine et al. BONE
- The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis
- (2009) Athanasios D. Anastasilakis et al. CLINICAL ENDOCRINOLOGY
- Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects
- (2009) Wei Yao et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice
- (2009) Ina Kramer et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Role of Smad3, acting independently of transforming growth factor-β, in the early induction of Wnt-β-catenin signaling by parathyroid hormone in mouse osteoblastic cells
- (2009) Yoshifumi Inoue et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Critical Role of Activating Transcription Factor 4 in the Anabolic Actions of Parathyroid Hormone in Bone
- (2009) Shibing Yu et al. PLoS One
- Transcriptional Control of Skeletogenesis
- (2008) Gerard Karsenty Annual Review of Genomics and Human Genetics
- Wnt signaling: A win for bone
- (2008) Elke Piters et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Epidemiology of osteoporosis
- (2008) Christopher Holroyd et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- BMP signaling negatively regulates bone mass through sclerostin by inhibiting the canonical Wnt pathway
- (2008) N. Kamiya et al. DEVELOPMENT
- Parathyroid Hormone Increases Activating Transcription Factor 4 Expression and Activity in Osteoblasts: Requirement forOsteocalcinGene Expression
- (2008) Shibing Yu et al. ENDOCRINOLOGY
- Parathyroid hormone signaling through low-density lipoprotein-related protein 6
- (2008) M. Wan et al. GENES & DEVELOPMENT
- Exported 18-kDa Isoform of Fibroblast Growth Factor-2 Is a Critical Determinant of Bone Mass in Mice
- (2008) Liping Xiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Osteocyte-Derived Sclerostin Inhibits Bone Formation: Its Role in Bone Morphogenetic Protein and Wnt Signaling
- (2008) Peter ten Dijke et al. JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
- Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease
- (2008) P. Bovolenta et al. JOURNAL OF CELL SCIENCE
- Endogenous FGF-2 is critically important in PTH anabolic effects on bone
- (2008) Maria Giovanna Sabbieti et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Reduced expression and function of bone morphogenetic protein-2 in bones of Fgf2 null mice
- (2007) Takahiro Naganawa et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3β in osteoblastic Saos-2 cells
- (2007) Akira Suzuki et al. JOURNAL OF CELLULAR BIOCHEMISTRY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started